Novo Nordisk Accuses Hims & Hers of ‘Illegal Mass Compounding' Over Cheaper Wegovy Version
Hims(US:HIMS) WSJ·2026-02-06 01:30公司业务动态 - Hims & Hers公司宣布将开始提供Wegovy的仿制药[1] - 该仿制药的推广期首月价格为49美元[1] - 该价格适用于一项为期五个月的计划[1]
Hims(US:HIMS) WSJ·2026-02-06 01:30Hims(US:HIMS) WSJ·2026-02-06 01:30